- 88.6k views
Hepatitis B & C: Overview
Hepatitis B and C are two distinct viral infections that affect the liver, causing a range of liver-related diseases. Hepatitis B is primarily transmitted through exposure to infected blood and other bodily fluids. It can be acute or chronic, with chronic infections posing a higher risk of liver cirrhosis and liver cancer.Hepatitis C is caused by the hepatitis C virus, typically transmitted through blood-to-blood contact. Chronic HCV infection can also lead to liver cirrhosis and liver cancer. Both HBV and HCV can be asymptomatic or present with similar symptoms, including jaundice, fatigue, and abdominal discomfort. HBV can be transmitted from an infected mother to her baby during childbirth, through sexual contact, and sharing needles. HCV is primarily spread through sharing needles, contaminated medical equipment, or in rare cases, sexual contact. Both diseases are global health concerns. HBV is more common in regions like Asia and Africa, while HCV is more prevalent in some parts of the United States and Europe. There is an effective vaccine for HBV that has significantly reduced new infections. No vaccine for HCV exists, but direct-acting antiviral drugs have revolutionized HCV treatment. Chronic hepatitis B can be managed with antiviral medications, while hepatitis C can be cured with a combination of antiviral drugs.
About the Speaker
Dr. Uday Sanglodkar
Senior Consultant - Hepatology and Liver Transplant Global Hospital, Mumbai
About the Speaker Dr. Uday Sanglodkar is currently working as Senior Consultant - Hepatology and Liver Transplant Clinical Lead Liver intensive care. Dr Uday has worked at Rela Institute and Medical centre (RIMC) as a Consultant Hepatologist and Liver Transplant physician for 3 years. Dr Uday is a Senior Consultant with vast experience in hepatology/ transplant Hepatology. His areas of interest include Hepatobiliary diseases, liver intensive care and transplant Hepatology.
Upcoming Case Discussions
Acne: Disorders and Treatment Approaches
Acne is a common dermatological condition caused by clogged pores, excess sebum production, bacterial growth, and inflammation. It can manifest as blackheads, whiteheads, papules, pustules, or cysts, often leading to scarring if untreated. Various factors, including hormonal changes, diet, stress, and genetics, influence its severity. Treatment approaches range from topical and oral medications, such as retinoids, antibiotics, and hormonal therapy, to advanced procedures like chemical peels and laser therapy. A personalized skincare regimen, along with lifestyle modifications, plays a crucial role in managing and preventing acne.
Congenital Uterine Anomalies
Congenital uterine anomalies are structural abnormalities of the uterus resulting from improper fusion, canalization, or resorption of the Müllerian ducts during fetal development. These anomalies include septate, bicornuate, unicornuate, and didelphys uterus, among others. They can be asymptomatic or associated with infertility, recurrent pregnancy loss, preterm birth, or abnormal menstruation. Diagnosis is typically made using imaging modalities like ultrasound, MRI, or hysterosalpingography. Treatment depends on the type and severity of the anomaly, with surgical correction such as hysteroscopic septum resection often indicated in symptomatic cases. Early detection is crucial for optimizing reproductive outcomes and guiding appropriate management strategies.
Management of Postoperative Pain: Best Practices for GP’s
Effective management of postoperative pain is crucial for promoting recovery and preventing complications. General practitioners should start by assessing pain severity using appropriate scales, then tailor the treatment plan based on the patient's medical history and the type of surgery. A combination of pharmacological approaches, such as non-opioid analgesics (e.g., NSAIDs) and opioids when necessary, should be used to minimize pain while reducing the risk of addiction. Multimodal strategies, including physical therapy and non-pharmacological techniques like cold therapy or mindfulness, can further enhance pain relief. Close follow-up is essential to adjust the treatment as needed and ensure the patient's pain is well-controlled.
Diabetes and Stem Cells: What Does the Future Hold?
The future of diabetes treatment may be revolutionized by stem cell research, offering hope for a long-term cure. Scientists are developing stem cell therapies that could regenerate insulin-producing beta cells in the pancreas, potentially restoring natural insulin production in people with type 1 diabetes. Early clinical trials have shown promising results, with some patients reducing or eliminating their need for insulin injections. While challenges like immune rejection and long-term efficacy remain, continued advancements suggest stem cell therapy could significantly change diabetes management in the coming years.
Author Post
Impact
+
Talks
+
webinar
+
no.of registrations
One liner about speaker
Why is speaker relevant?
Dr. Uday Sanglodkar 's Talks on Assimilate
- 10th-November-2023, TIME : 03:00PM - 04:00PM
- 0
Hepatitis B and C are two distinct viral infections that affect the liver, causing a range of liver-related diseases. Hepatitis B is primarily transmitted through exposure to infected blood and other bodily fluids. It can be acute or chronic, with chronic infections posing a higher risk of liver cirrhosis and liver cancer.Hepatitis C is caused by the hepatitis C virus, typically transmitted through blood-to-blood contact. Chronic HCV infection can also lead to liver cirrhosis and liver cancer. Both HBV and HCV can be asymptomatic or present with similar symptoms, including jaundice, fatigue, and abdominal discomfort. HBV can be transmitted from an infected mother to her baby during childbirth, through sexual contact, and sharing needles. HCV is primarily spread through sharing needles, contaminated medical equipment, or in rare cases, sexual contact. Both diseases are global health concerns. HBV is more common in regions like Asia and Africa, while HCV is more prevalent in some parts of the United States and Europe. There is an effective vaccine for HBV that has significantly reduced new infections. No vaccine for HCV exists, but direct-acting antiviral drugs have revolutionized HCV treatment. Chronic hepatitis B can be managed with antiviral medications, while hepatitis C can be cured with a combination of antiviral drugs.
- 10th-November-2023, TIME : 03:00PM - 04:00PM
- 0
Hepatitis B and C are two distinct viral infections that affect the liver, causing a range of liver-related diseases. Hepatitis B is primarily transmitted through exposure to infected blood and other bodily fluids. It can be acute or chronic, with chronic infections posing a higher risk of liver cirrhosis and liver cancer.Hepatitis C is caused by the hepatitis C virus, typically transmitted through blood-to-blood contact. Chronic HCV infection can also lead to liver cirrhosis and liver cancer. Both HBV and HCV can be asymptomatic or present with similar symptoms, including jaundice, fatigue, and abdominal discomfort. HBV can be transmitted from an infected mother to her baby during childbirth, through sexual contact, and sharing needles. HCV is primarily spread through sharing needles, contaminated medical equipment, or in rare cases, sexual contact. Both diseases are global health concerns. HBV is more common in regions like Asia and Africa, while HCV is more prevalent in some parts of the United States and Europe. There is an effective vaccine for HBV that has significantly reduced new infections. No vaccine for HCV exists, but direct-acting antiviral drugs have revolutionized HCV treatment. Chronic hepatitis B can be managed with antiviral medications, while hepatitis C can be cured with a combination of antiviral drugs.